• Registry for Shoulder Surgery Outcomes

    Official Title

    Shoulder Surgery Outcomes Registry

    Purpose

    This registry will collect outcomes data of patients undergoing shoulder surgery with Dr. Jonathan Barlow or Dr. Julie Bishop. The purpose of this registry is to provide a way to collect and store data for patients undergoing shoulder surgery to support the conduct of future research in an effort to improve patient outcomes.

    Could this study be right for you?

    - A patient undergoing surgery with Dr Jonathan Barlow or Dr Julie Bishop (will be asked to enroll once the clinical decision has been made to proceed with surgery)
    - 18 to 89 years old
    - Able to provide consent

    Age Range

    18 and up
  • Rotator Cuff Study--For Those Who Require Surgical Treatment for Full Thickness Massive Tear

    Official Title

    A prospective, single blinded, multi-center, randomized, controlled, pivotal study to assess the safety and effectiveness of the InSpace™ device for treatment of full thickness Massive Rotator Cuff Tears

    Purpose

    This research study will evaluate a new device, InSpace, for use with a full thickness massive tear of rotator cuff (the group of connective tissues in the shoulder). The device is designed to allow smooth gliding of the bones in the shoulder during motion, which may allow rehabilitation exercises with less pain. The research study is being conducted to see whether the InSpace device is safe and effective for shoulder problems due to a full thickness massive rotator cuff tear.

    Could this study be right for you?

    1) Is male or female ≥ forty (40) years of age
    2) Positive diagnostic imaging by MRI within 9 months of enrollment of the index shoulder indicating a full thickness MRCT: measuring ≥ 5 cm in diameter (Cofield classification) and involving ≥ two tendons
    3) Functional deltoid muscle and preserved passive range of motion on physical examination
    4) Failed non-operative treatment of at least 4 months from the initial treatment to include one or all of the following: Oral analgesics, Anti-inflammatory medication (e.g., ibuprofen, naproxen), Corticosteroid injection(s), Physical therapy, Activity modification, or Rest (sling used)
    5) Must be able to read and understand the approved Informed Consent Form (written and oral)
    6) Must be in general good health (as determined by the Investigator) based on screening assessments and medical history
    7) Must be independent, ambulatory, and can comply with all post-operative evaluations and visits.

    Other details will be shared by the study coordinator.

    Age Range

    40 and up
  • A Treatment Study for Single Articular Cartilage Lesion of the Knee--NOVOCART®3D (N3D)

    Official Title

    A Phase 3 Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART® 3D, Compared to Microfracture in the Treatment of Articular Cartilage Defects

    Purpose

    The purpose of this research study is to evaluate an investigational procedure for treatment of knee cartilage defects. If eligible, you will receive one of two possible surgical procedures. One is the investigational procedure under study, utilizes the Novocart® 3D autologous cartilage implant system. The other possible procedure is called Microfracture and is one of the current standard of care options to treat your condition. Both surgical procedures will be followed by pain and knee function assessments and a course of physical rehabilitation.

    Could this study be right for you?

    Inclusion Criteria:
    --Ages 18-65
    •Little response to conservative treatment (non-operative treatments such as physical therapy, weight loss)
    •Single articular cartilage lesion on the femoral condyle (round projection at the end of the femur) 2-6 cm2
    •BMI less than 40

    Exclusion Criteria:
    •Instability of the knee joint
    •Arthritis
    •Autoimmune disease
    •Immune suppression
    •Prior surgical treatment using mosaicplasty, autologous chondrocyte implantation and/or microfracture (debridement and lavage are acceptable beyond three months from baseline)
    •Bone disease
    •Any degenerative muscular, connective tissue or neurological condition or other disease process that would interfere with healing or the evaluation of outcome measures.

    Age Range

    18 and up
  • The Effects of Dry Needling on Knee Pain

    Official Title

    The Effects of Dry Needling on Patients with Knee Pain

    Purpose

    This study is testing the effectiveness of "dry needling" for pain management and on muscle strength and leg function for those with knee pain. Dry needling consists of small, monofilament needles that are administered directly into the tissue and manipulated to make the muscle relax for pain relief. This technique is used to treat dysfunctions in skeletal muscle and connective tissue to help diminish pain, reduce impairments of body structure and restore function.

    Could this study be right for you?

    Eligibility Criteria:
    --Ages 18-40
    --Referred for physical therapy
    --Presence of knee pain (for at least 3 months) around the knee cap (patella) during ascending/descending stairs, squatting, and/or running.

    Age Range

    18 and up
  • Ankle Function Study for Healthy Volunteers OR Those with Ankle Instability or Nerve Damage

    Official Title

    Assessing Reliability and Validity of an iPod App for Measuring Ankle Proprioception

    Purpose

    We will assess ankle function by measuring how well you detect ankle movement using an iPod app. This information will help us to determine the validity of using an iPod app as a clinical tool for measuring ankle function and perception of rotation

    The results of this study may inform us if the iPod app is an appropriate tool to use in the clinical setting as a more cost-effective, faster, and accessible tool when compared to the larger, more expensive Biodex machine.

    Could this study be right for you?

    Three groups (ages 18-80) are eligible for this study:

    --Group 1--Those who are 60-80 years old, without history of ankle instability or nerve damage to lower extremities.

    --Group 2--Those who are 18-60 years old and have a history of chronic ankle instability, recurrent ankle sprains. Have had at least 3 ankle sprains in the previous two (2) years, but none within 2 months of joining the study

    --Group 3--Those who are 18-60 years old and have been diagnosed with peripheral neuropathy that has been induced by chemotherapy. Further screening will be done by the study team.

    Age Range

    18 and up